MAPT and Alzheimer disease: Several studies have characterized AD subtypes by looking at pathological burden based on Aβ, tau, and cerebrovascular factors independently (Whitwell et al., 2012; Risacher et al., 2017; Ferreira et al., 2018; Ten et al., 2018; Ossenkoppele et al., 2019; Vogel et al., 2021).